down arrow

Suven Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE03QK01018
  • NSEID: SUVENPHAR
  • BSEID: 543064
INR
1,120.85
68.65 (6.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.22 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,071.001,136.75

52 Week

597.001,359.00
Valuation
Technical
Day's Volume

CASH

3.22 lacs (47.72%) Volume

Shareholding (Dec 2024)

FII

10.84%

Held by 152 FIIs

DII

16.69%

Held by 25 DIIs

Promoter

50.10%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 24.43%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Operating profit has grown by an annual rate -5.48% of over the last 5 years

 
4

Positive results in Dec 24

5

Stock is technically in a Mildly Bullish range

6

With ROE of 12.3, it has a Very Expensive valuation with a 13.5 Price to Book Value

7

High Institutional Holdings at 27.53%

8

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 28,533 Cr (Large Cap)

stock-summary
P/E

96.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

12.29%

stock-summary
Price to Book

13.54

Revenue and Profits (1 Year):
Net Sales:
307 Cr
(Quarterly Results - Dec 2024)
Net Profit:
83 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-6.56%
0%
-6.56%
1 Year
82.02%
0%
82.02%
2 Years
140.94%
0%
140.94%
3 Years
85.0%
1.16%
86.16%
4 Years
127.79%
1.70%
129.49%
5 Years
623.13%
0%
623.13%

Latest dividend: 5 per share ex-dividend date: Sep-09-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
3.10%
EBIT Growth (5y)
-5.48%
EBIT to Interest (avg)
57.78
Debt to EBITDA (avg)
0.23
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.71
Tax Ratio
23.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
27.53%
ROCE (avg)
36.25%
ROE (avg)
24.43%
Valuation key factors
Factor
Value
P/E Ratio
96
Industry P/E
33
Price to Book Value
13.54
EV to EBIT
85.22
EV to EBITDA
69.77
EV to Capital Employed
19.29
EV to Sales
24.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.38%
ROE (Latest)
12.29%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 27 Schemes (13.15%)

FIIs

Held by 152 FIIs (10.84%)

Promoter with highest holding

Berhyanda Limited (50.1%)

Highest Public shareholder

Jasti Property And Equity Holdings Private Limited (9.9%)

Individual Investors Holdings

9.81%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 19.18% vs 11.72% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 0.81% vs 35.28% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "307.15",
          "val2": "257.72",
          "chgp": "19.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "117.70",
          "val2": "104.01",
          "chgp": "13.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.33",
          "val2": "1.67",
          "chgp": "99.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "82.88",
          "val2": "82.21",
          "chgp": "0.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.32%",
          "val2": "40.36%",
          "chgp": "-2.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -15.59% vs -6.25% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -28.56% vs 11.44% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "488.41",
          "val2": "578.60",
          "chgp": "-15.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "183.94",
          "val2": "264.92",
          "chgp": "-30.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.27",
          "val2": "1.65",
          "chgp": "98.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "142.98",
          "val2": "200.15",
          "chgp": "-28.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.66%",
          "val2": "45.79%",
          "chgp": "-8.13%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -0.36% vs -17.77% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -8.52% vs -14.07% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "795.56",
          "val2": "798.42",
          "chgp": "-0.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "301.64",
          "val2": "331.00",
          "chgp": "-8.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.60",
          "val2": "3.81",
          "chgp": "73.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "225.86",
          "val2": "246.90",
          "chgp": "-8.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.92%",
          "val2": "41.46%",
          "chgp": "-3.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -21.56% vs 1.52% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -26.99% vs -9.37% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,051.35",
          "val2": "1,340.33",
          "chgp": "-21.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "405.81",
          "val2": "574.17",
          "chgp": "-29.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.45",
          "val2": "12.81",
          "chgp": "-41.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "300.28",
          "val2": "411.29",
          "chgp": "-26.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.60%",
          "val2": "42.84%",
          "chgp": "-4.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
307.15
257.72
19.18%
Operating Profit (PBDIT) excl Other Income
117.70
104.01
13.16%
Interest
3.33
1.67
99.40%
Exceptional Items
0.00
0.00
Consolidate Net Profit
82.88
82.21
0.81%
Operating Profit Margin (Excl OI)
38.32%
40.36%
-2.04%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 19.18% vs 11.72% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 0.81% vs 35.28% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
488.41
578.60
-15.59%
Operating Profit (PBDIT) excl Other Income
183.94
264.92
-30.57%
Interest
3.27
1.65
98.18%
Exceptional Items
0.00
0.00
Consolidate Net Profit
142.98
200.15
-28.56%
Operating Profit Margin (Excl OI)
37.66%
45.79%
-8.13%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -15.59% vs -6.25% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -28.56% vs 11.44% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
795.56
798.42
-0.36%
Operating Profit (PBDIT) excl Other Income
301.64
331.00
-8.87%
Interest
6.60
3.81
73.23%
Exceptional Items
0.00
0.00
Consolidate Net Profit
225.86
246.90
-8.52%
Operating Profit Margin (Excl OI)
37.92%
41.46%
-3.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -0.36% vs -17.77% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -8.52% vs -14.07% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,051.35
1,340.33
-21.56%
Operating Profit (PBDIT) excl Other Income
405.81
574.17
-29.32%
Interest
7.45
12.81
-41.84%
Exceptional Items
0.00
0.00
Consolidate Net Profit
300.28
411.29
-26.99%
Operating Profit Margin (Excl OI)
38.60%
42.84%
-4.24%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -21.56% vs 1.52% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -26.99% vs -9.37% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Suven Pharmaceuticals Ltd stock-summary
stock-summary
Suven Pharmaceuticals Ltd
Large Cap
Pharmaceuticals & Drugs
Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."